DRAXIS Health (DRAX) in Discussions Regarding Potential Transaction That Could Lead to Sale of the Company
DRAXIS Health Inc. (NASDAQ: DRAX), in response to a request by securities regulators with respect to increased trading in its common stock, announced today that it is currently in exclusive discussions regarding a potential transaction that could lead to a sale of the Company. There can be no certainty at this stage that these discussions will continue or result in any agreement or transaction or result in pricing that will be acceptable either to the board of directors of the Company or to shareholders.
DRAXIS Health Inc. (DRAXIS) is a specialty pharmaceutical company providing products in three categories: sterile products, non-sterile products and radiopharmaceuticals.
DRAXIS Health Inc. (DRAXIS) is a specialty pharmaceutical company providing products in three categories: sterile products, non-sterile products and radiopharmaceuticals.
You May Also Be Interested In
- UPDATE: Angelo, Gordon to Acquire Benihana (BNHN) for $16.30/Share in Cash
- Citi (C) selling stake in Turkey's Akbank, valued at $1.27B -Bloomberg
- Dollar Thrifty (DTG) Shares Spike Higher as Hertz (HTZ) Could Make an Offer
Create E-mail Alert Related Categories
Hot List, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
